SELLAS Life Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLS and other ETFs, options, and stocks.

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S.

CEO

Angelos M. Stergiou

CEOAngelos M. Stergiou

Employees

Employees16

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2006

Founded2006

Employees

Employees16

SLS Key Statistics

Market cap

68.65M

Market cap68.65M

Price-Earnings ratio

-0.89

Price-Earnings ratio-0.89

Dividend yield

—

Dividend yield—

Average volume

1.54M

Average volume1.54M

High today

$1.67

High today$1.67

Low today

$1.09

Low today$1.09

Open price

$1.33

Open price$1.33

Volume

3.33M

Volume3.33M

52 Week high

$1.91

52 Week high$1.91

52 Week low

$0.4986

52 Week low$0.4986

SELLAS Life Sciences

Why Robinhood?

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. Show more

SLS Key Statistics

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S.